Deutsche Telekom looks overvalued vs. fundamentals, keeping risk elevated. Read here for a detailed investment details of ...

Healthpeak Properties (DOC) benefits from South San Francisco life-science demand and stable outpatient cash flow. See more ...

Inspire 500 ETF review: faith-based screens add a quality cost. Inspire screens for "violations" and "excellence". Read here ...

Invesco Variable Rate Investment Grade ETF analysis: ultra-low duration, 4.8% SEC yield, ~100 bps over T-bills, and strong ...

Calumet (CLMT) poised for big EBITDA growth through 2026–2028 as SAF margins expand and ops improve. Read here for more ...

YieldMax's CHPY ETF beats the S&P 500 with 31% growth since April 2025, driven by semiconductors and strong distributions.

Lionsgate (LION) stock was downgraded to sell after Q2 revenue plunged 42% y/y, leverage hit 6.5x, and valuation stretched.

AI, electrification & smart manufacturing tailwinds plus vacuum recovery and resilient service revenue. See more details here ...

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

After five days of gains, oil prices came under significant pressure yesterday, with ICE Brent settling 4.15% lower.

Shares MSCI Australia ETF (EWA) outlook: strong 1-year return but lags peers. EWA is close to hitting multi-year resistances.

YPF Sociedad Anonima (YPF) continues to focus on shale in the Vaca Muerta. Read more on what investors should know about this ...